Raute’s Q2 revenue and earnings were a lot higher than we estimated as performance improved thanks t...
CapMan's turnover in Q2 amounted to EUR 18.3m, above our estimates and consensus (EUR 16.
CapMan reported Q2 Adj. EBIT of 5.8m, 4% below LSEG Data & Analytics consensus at EUR 6.
Sales -1% vs. ABGSC, driving 7% adj. EBIT miss We see consensus estimates coming down 2-3% Conferenc...
Q2 sales low due to delivery delay, SEK 12m already secure for H2 Elevated opex due to new and repla...
Redeye states that Q2 2024 was solid, beating estimates across the board.
Redeye updates on Embracer ahead of Q1-results (due 15 Aug) where we expect a slow quarter with few ...
Redeye updates its estimates and valuation after reviewing Fantasma Games’ Q2 report, which came in ...
Strong SBU and IBU sales helped DT Q2 earnings clearly above estimates as they made up for the weakn...
Redeye comments on Sivers’ announcement about its Photonics business will be separated and merged in...
Redeye comments on Fantasma Games’ Q2 results, which exceeded expectations in both sales and margins...
Redeye updates its estimates and valuation following Freemelt’s Q2 report, which came in below our e...
Scanfil's Q2 net sales and clean EBIT were slightly below LSEG Data & Analytics consensus.
NoHo Partners' Q2 2024 results missed the Vara Research consensus' high expectations, but we neverth...
Aspo had a weak start to the year in Q1, but yields in the dry bulk sector have been good in Q2.
Redeye is positive to the news of FiiZK divesting its lice skirt business FiiZK Protection AS.
Redeye provides a research update following the Q2 2024 report from Respiratorius.
Q2 adj. EBIT of GBP 26m, below ABGSCe at GBP 35m Slight AUM miss driven by CS Physical Q2 worse than...
Redeye states that CoinShares’ (CS) report was solid and came in better than expected on most metric...
Redeye comments on Freemelt’s Q2 results, which came in lower than expected because some anticipated...
